Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
Immunology
[키워드] Activation
Atypical
Autoimmune
autoimmune hemolytic anemia
benefit
CAD
carried
clinically
Cold agglutinin disease
complement
Complement inhibitor
complex
Complication
condition
COVID-19
COVID-19 disease
COVID-19 infection
COVID19 vaccine
disease
dose
greater
Hemodialysis
hemolytic
hemolytic anemia
hemolytic uremic syndrome
include
Infection
inhibitor
Laboratory
LDH
literature
manuscript
Mediated
occur
occurred
Occurrence
paroxysmal nocturnal hemoglobinuria
pathophysiologic
Patient
Patient education
patient population
plasma
Platelet
Prophylaxis
provided
recognize
required
review
Safe
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccine
Sery
severity
steroid
subject
therapeutic intervention
Thrombotic complications
Treatment
Trigger
uremic syndrome
Vaccine
warm
[DOI] 10.3389/fimmu.2021.791429 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.791429 PMC 바로가기 [Article Type] Immunology